Peethaambaran Kunnathoor, Chennai Friday, January 10, 2025, 08:00 Hrs [IST] ...
NCH amends BHMS regulations to add goals, restructure curriculum and assessment process: Gireesh Babu, New Delhi Friday, ...
DHR invites senior scientists to lead evidence-based healthcare initiatives in India: Shardul Nautiyal, Mumbai Friday, January 10, 2025, 08:00 Hrs [IST] The Department of Health R ...
FPME demands policy reforms to address critical issues hampering export ecosystem: Shardul Nautiyal, Mumbai Friday, January 10, 2025, 08:00 Hrs [IST] The Federation of Pharmaceuti ...
KSRPO concerned over growing number of medical shops across the state: Nandita Vijayasimha, Bengaluru Friday, January 10, 2025, 08:00 Hrs [IST] The Karnataka State Registered Phar ...
Alloy Therapeutics announces target specific collaboration & license agreement for use of AntiClastic Antisense platform with Sanofi for CNS target: Boston, Massachusetts Thursday ...
ModeX Therapeutics announces Epstein-Barr virus vaccine candidate enters phase I study in collaboration with Merck: Weston, Massachusetts Thursday, January 9, 2025, 18:00 Hrs [IST ...
Charlestown, Massachusetts Thursday, January 9, 2025, 14:30 Hrs [IST] ...
Lilly to establish new global capability centre in Hyderabad, India to hire over 1,000 skilled teams: Our Bureau, Bengaluru Thursday, January 9, 2025, 15:30 Hrs [IST] Eli Lilly an ...
Lupin receives US FDA tentative approval for loteprednol etabonate ophthalmic gel: Our Bureau, Mumbai Thursday, January 9, 2025, 17:20 Hrs [IST] Global pharma major Lupin Limited ...
Illumina advances NovaSeq X Series, delivering single-flow-cell system, software upgrade, and new kits to enable multiomic applications: San Diego Thursday, January 9, 2025, 14:00 ...
US FDA accepts and grants priority review status to Dizal’s sunvozertinib NDA in relapsed or refractory NSCLC patients with EGFR exon20ins: Shanghai Thursday, January 9, 2025, 1 ...